Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$2.64 - $4.84 $15,945 - $29,233
-6,040 Reduced 19.09%
25,600 $68,000
Q1 2022

Apr 25, 2022

BUY
$3.5 - $5.3 $66,640 - $100,912
19,040 Added 151.11%
31,640 $137,000
Q4 2021

Jan 10, 2022

BUY
$4.45 - $6.21 $56,070 - $78,246
12,600 New
12,600 $65,000
Q3 2021

Oct 13, 2021

SELL
$6.14 - $10.1 $30,700 - $50,500
-5,000 Closed
0 $0
Q2 2021

Jul 14, 2021

BUY
$9.04 - $14.19 $45,199 - $70,950
5,000 New
5,000 $50,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $297M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.